CD36 and ovarian carcinoma: More specifically, retrospective analyses suggest that elevated levels of CD36 correlate with poor prognosis in patients with glioma, cervical cancer, ovarian cancer, lung cancer, squamous-cell carcinoma, bladder cancer, and luminal A breast cancer [27–30].